IP Library Granted Patent US 7,307,146
Granted Patent B2
US 7,307,146 · App. 11/351,190 · Granted Dec 11, 2007

DNAXCCR10

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,307,146
App. No.
11/351,190
Granted
Dec 11, 2007
Kind
B2
Abstract

Novel chemokines and 7 transmembrane receptors from mammals, reagents related thereto, including purified proteins, specific antibodies, and nucleic acids encoding the chemokines and receptors are disclosed. Methods of using the chemokines, receptors, reagents and diagnostic kits are also provided.

Claims (7)

1. An isolated polypeptide comprising the amino acid sequence set forth in SEQ ID NO: 10.

2. The polypeptide of claim 1 bound to MIP-3α.

3. The polypeptide of claim 1 which is detectably labeled.

4. The polypeptide of claim 3 wherein the label is 125 I.

5. The polypeptide of claim 1 fused to a heterologous protein.

6. The polypeptide of claim 5 wherein the heterologous protein is a member selected from the group consisting of luciferase, bacterial β-galactosidase, trpE, Protein A, β-lactamase, alpha amylase, alcohol dehydrogenase, a FLAG tag, and yeast alpha mating factor.

7. The polypeptide of claim 1 complexed with an antibody.

Assignments (1)
CHANGE OF NAME Recorded Aug 30, 2012
From: SCHERING CORPORATION
To: MERCK SHARP & DOHME CORP.
Reel/Frame 028884/0151 →